C. Cavanaugh

Activity of paclitaxel liposome formulations against human ovarian tumor xenografts

A. Janoff, Amarnath Sharma, E. Mayhew, 1997, International journal of cancer.

Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II Trial.

J. Burke, A. Eisen, M. Kohli, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Activity, pharmacokinetics and tissue distribution of TLC ELL-12 (liposomal antitumor ether lipid) in rats with transplantable, s.c. methylnitrosourea-induced tumors

I. Ahmad, J. Schupsky, C. Swenson, 2003, Anti-cancer drugs.

Toxicity and disposition of TLC ELL-12 (liposomal antitumor ether lipid) in Sprague-Dawley rats

C. Swenson, P. Roberts, R. Stevens, 2003, Anti-Cancer Drugs.

2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma

J. Burke, A. Eisen, M. Kohli, 2015 .